Click to view your profile
Click to search for condition or expert
Click to open main menu
Familial Hypertriglyceridemia Latest Advances
Find the Latest Research About Familial Hypertriglyceridemia
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/20/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications
See more filters
Sintilimab plus autologous NK cells as second-line treatment for advanced non-small-cell lung cancer previous treated with platinum-containing chemotherapy.
Condition:
Non-Small Cell Lung Cancer (NSCLC)
Journal:
Frontiers in immunology
Treatment Used:
Sintilimab Plus Autologous NK Cells
Number of Patients:
20
Published:
December 26, 2022
VIEW PUBLICATION
Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study: Volanesorsen in FPLD; The BROADEN Study.
Condition:
Familial Partial Lipodystrophy (FPLD) and Concomitant Hypertriglyceridemia and Diabetes
Journal:
Journal of clinical lipidology
Treatment Used:
Volanesorsen
Number of Patients:
40
Published:
November 19, 2022
VIEW PUBLICATION
Tolerance and response to ketogenic therapy in neonates and infants younger than 4 months. Case series in a hospital center in Medellin, Colombia.
Condition:
Neonates with Refractory Epilepsy
Journal:
Revista de neurologia
Treatment Used:
Ketogenic Therapy (KT)
Number of Patients:
7
Published:
November 10, 2022
VIEW PUBLICATION
Anlotinib plus chemotherapy for T790M-negative EGFR-mutant non-sqNSCLC resistant to TKIs: A multicenter phase 1b/2 trial.
Condition:
T790M-Negative EGFR-Mutant Non-Squamous Cell Non-Small Cell Lung Cancer (NSCLC)
Journal:
Thoracic cancer
Treatment Used:
Anlotinib Plus Chemotherapy
Number of Patients:
19
Published:
November 08, 2022
VIEW PUBLICATION
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Condition:
Hypertriglyceridemia
Journal:
The New England journal of medicine
Treatment Used:
Pemafibrate
Number of Patients:
10497
Published:
November 07, 2022
VIEW PUBLICATION
Long-term safety and efficacy of MND-2119 (self-emulsifying formulation of highly purified eicosapentaenoic acid ethyl ester) in patients with hypertriglyceridemia: Results from a multicenter, 52-week, open-label study.
Condition:
Hypertriglyceridemia
Journal:
Journal of clinical lipidology
Treatment Used:
MND-2119
Number of Patients:
0
Published:
October 06, 2022
VIEW PUBLICATION
Hypertriglyceridaemia in pregnancy: an unexpected diagnosis and its management.
Condition:
Hypertriglyceridemia in Pregnancy
Journal:
BMJ case reports
Treatment Used:
Fat-Free Diet
Number of Patients:
1
Published:
August 29, 2022
VIEW PUBLICATION
Efficacy and safety of self-emulsifying formulation of highly purified eicosapentaenoic acid ethyl ester (MND-2119) versus highly purified eicosapentaenoic acid ethyl ester in patients with hypertriglyceridemia: Results from a 12-week randomized, double-blind, active-controlled, phase 3 study.
Condition:
Hypertriglyceridemia
Journal:
Journal of clinical lipidology
Treatment Used:
Highly Purified Eicosapentaenoic Acid Ethyl Ester (MND-2119) vs. Eicosapentaenoic Acid Ethyl Ester (EPA-E)
Number of Patients:
0
Published:
July 23, 2022
VIEW PUBLICATION
Safety and efficacy of therapies for chylomicronemia.
Condition:
Chylomicronemia
Journal:
Expert review of clinical pharmacology
Treatment Used:
Low-Fat Diet and Triglyceride-Lowering Therapies
Number of Patients:
0
Published:
June 28, 2022
VIEW PUBLICATION
Phase II Study of Lorlatinib in Patients With Anaplastic Lymphoma Kinase-Positive Lung Cancer and CNS-Specific Relapse.
Condition:
Anaplastic Lymphoma Kinase-Positive Lung Cancer and CNS-Specific Relapse
Journal:
JCO precision oncology
Treatment Used:
Lorlatinib
Number of Patients:
23
Published:
May 18, 2022
VIEW PUBLICATION
Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.
Condition:
Prior Myocardial Infarction (MI)
Journal:
Journal of the American College of Cardiology
Treatment Used:
Icosapent Ethyl
Number of Patients:
3693
Published:
April 28, 2022
VIEW PUBLICATION
Successful treatment of severe hypertriglyceridemia with icosapent ethyl in a case of congenital generalized lipodystrophy type 4.
Condition:
Severe Hypertriglyceridemia in Congenital Generalized Lipodystrophy Type 4
Journal:
Journal of pediatric endocrinology & metabolism : JPEM
Treatment Used:
Icosapent Ethyl
Number of Patients:
1
Published:
April 13, 2022
VIEW PUBLICATION
Showing 1-12 of 131
Next
Last Updated: 01/20/2023